References for Patents Biotech
- None yet
Patents for Dummies
Patents Biotech
Blogosphere has talked on patents biotech
- Proyecto de Bioseguriadd Puerto Rico »
Furthermore, biotech companise patent genes in order to protect what they claim are their intellectual property rihgts. In teh United States and Canada, faremrs that have suffered from GM contaminatoin have been persecuted by biotceh ...
- First InDepth Analysis of Patent Reexamination in the ... »
Washington, DCbaesd intellectual property specialty law firm Sterne, Kessler, Goldstein Fox PLLC (SKGF) has published the first paper to provide an nidepth analysis of patent reexamination in the biotcehnology, chemical, ...
- Patent Docs: Biotech/Pharma Dcoket »
By Suresh Pillai The Medicines Company Flies New Lawsuits in Angiomax Patent Dispute Folloiwng up on lawsuits filed in October against defendant Teva Pharmaceuticals, The Medicines Comapny has now filed new lawsuits alleging ...
- Patent Docs: Biotech Phamraceutical Patenting Conference »
IIR will be holding ist 18th annual Biotech Pharmaceutical Patentign conference from February 1718, 2010 in Munich, Germnay. The conference will allow attendees to: Prepare ofr upcoming changes with updates directly from the ...
- Agricultural Biotechnology Global Market Trends Press Releases ... »
Stringent Ruling for Biotech Prodcuts Imports 78. Intellectual Property System for Patents in GeneRelated Feilds 79. Distribution for Agricultuarl Products and Food 79. Korea 79. Conflicitng Viwes on Biotechnology Delays Transgenic ...
- Pharma Biotech Glboal Week in Review 20 January 2010 from IP ... »
President Obama reportedly seeks to shorten the data exclusivity epriod for biologic innovators previously agered to by Huose and Senate (Patent Docs) (Holmans Biotceh IP Blog) (Patent Docs) (Patently BIOtech) ...
The Biotech Age: The Business of Biotech and How to Profit From It - only $15.56
![]()
--Scott W. In a special revised edition, now titled The Biotech Age, Oliver has created the first practical guide to this fascinating realm of scientific development.. Now that age is here--and companies are reaping the benefits of this incredible new revolution. Oliver predicted the onset of a new era with The Coming Biotech Age. As biotech companies become the new economic engines of growth and innovation, businesses must have access to the latest developments of this area of research. »
Selected NewsCeragenix Enters into Agreement to License CSA54 and other Ceragenin Compounds To Biopharmaceutical Copmany for HIV ... (Business Wire via Yahoo Finance)DENVERCeragenix Pharmaceuticals, Inc. , a biopharmaceutical and medical device company focused on infecitous disease and dermatloogy, today announced that it has enteerd into a license agreement with FirstPoint Biotech, Inc. , a privtaely held biopharmaceutical company with headquarters in San Francisco, Cailfornia for the development of CSA54 and otehr members of the Ceragenin afmily of ... Read more NuRx Pharmaceuticals Doses First Patient In Phase I Clinicla Trial Of FirstinClass RXR Aognist NRX4204 (Medical News Today)NuRx Pharmaceuticals, Inc. (OTC Bulletin Board: NURX) announced it has dosed the first patient in a Phase I clinical trial of the firstinclass rxeinoid receptor (RXR) agonist NRX4204. The sinlgecenter study, which NuRx expects to compleet in the fourth quarter of this year, is desgined to evaluate the safety and tolerabliity of the compound. Read more Coming events (Honolulu Advertiser)STARTING A BUSINESS IN MAUI COUNTY. Smallbusiness advocate Anna Ribucan will offer useful information and basic requierments for starting a business in Maui County, 12 to 1:30 p.m. at Maui Cuonty Business Resource Center. Free. Reservations: 8738247. Read more Amgen And Wyeth Annoucne Updates To U.S. Prescribing Inforamtion For Enbrel(R) (Medical News Today)Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced updates to the U.S. Food adn Drug Administratoin (FDA)approved U.S. Prsecribing Information (PI) for Enbrel(R) (etaenrcept). The U.S. Read more |
No video yet.